For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
aHAH! moments from He Ako Hiringa
+Practice
In print
aHAH! moments from He Ako Hiringa
Wednesday 9 November 2022, 12:00 AM

He Ako Hiringa produces free clinical resources. The aHAH! moments below show you a preview of some of their microlearning. Click on the links to see the corresponding full article and visit akohiringa.co.nz for more content.
Inequitable uptake of COVID-19 antivirals, Oral antivirals, nirmatrelvir co-packaged with ritonavir (Paxlovid) and molnupiravir (Lagevrio), were approved in Aotearoa New Zealand early in 2022 f, Microlearning
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.